SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review

By S. Verma, J. McMurray. Diabetologia, 2018

847 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Surgery

View Paper: https://www.semanticscholar.org/paper/3bf8450ffbe869af31ffcdef6035cec664fe6dfb